STAT+: Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and more

STAT+: Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and more →

Seven months after the launch of its own low-cost insulin brand, California has distributed more than 120,000 five-pen packs of insulin glargine priced at $55 each